Open

Do GLP-1 receptor agonists cause more adverse events & safety than other treatments?

Also asked versus placebo.

Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →

Where the evidence stands

Doubtful. So far, the results disagree.

NoUnsureYes
Belief
0.22 (range 0.00–0.55)
Trials for
4
Trials against
14
Inconclusive
2

Already under way

No registered trial that could settle this is recruiting or active.

The evidence so far

Registered trials
594
With posted results
184
Published papers
44

Of 200 decided analyses: 124 favor glp-1 receptor agonists, 66 find no difference, 10 favor the comparator.

Papers

Trials

See every trial in the evidence map →